Lea Gattoni, DMSC, PA-C - Denver: Weight Loss | Cosmetic Injector

Lea Gattoni, DMSC, PA-C operates a specialized weight loss and metabolic health practice in Denver, Colorado, combining her doctoral-level training with a focused approach to GLP-1 receptor agonist therapy. With a 5.0-star rating across 31 patient reviews, the practice has established a reputation for clinical precision in obesity medicine and diabetes management. Dr. Gattoni's DMSC credential—a Doctor of Medical Science degree—represents advanced postgraduate training beyond standard physician assistant certification, positioning her to deliver evidence-based interventions for patients struggling with metabolic dysfunction and weight-related health complications.

The clinic's therapeutic approach centers on two FDA-approved GLP-1 medications: semaglutide and tirzepatide. Semaglutide, marketed under brand names including Wegovy and Ozempic, functions by mimicking the glucagon-like peptide-1 hormone to regulate appetite, slow gastric emptying, and improve insulin sensitivity. Tirzepatide represents a dual-action medication that activates both GLP-1 and GIP receptors, often producing more pronounced weight reduction in clinical trials. Dr. Gattoni prescribes these medications as part of comprehensive metabolic protocols that address underlying insulin resistance, inflammatory markers, and hormonal imbalances contributing to weight gain. Patients receive individualized dosing schedules based on their metabolic profile, comorbid conditions such as type 2 diabetes or hypertension, and response to initial treatment phases. The practice monitors hemoglobin A1c levels, fasting insulin, lipid panels, and body composition metrics throughout treatment to optimize outcomes and adjust protocols as needed.

Dr. Gattoni's clinical methodology integrates her background as a cosmetic injector with her metabolic health expertise, recognizing that many patients seeking weight loss also have aesthetic concerns related to skin laxity, facial volume changes, or body contouring. Her doctoral training in medical science informs a systems-based approach to obesity treatment, examining thyroid function, cortisol dysregulation, sex hormone imbalances, and nutrient deficiencies that may impede weight loss efforts. Patients undergo comprehensive intake assessments that include detailed medical histories, current medication reviews, and laboratory workups to identify contraindications or factors requiring protocol modifications. The practice serves Denver residents seeking alternatives to bariatric surgery or those who have experienced weight regain after previous interventions, as well as patients with prediabetes or metabolic syndrome looking to prevent disease progression.

Patients initiating GLP-1 therapy at the Denver clinic typically begin with low-dose protocols to minimize gastrointestinal side effects such as nausea or constipation, with gradual titration over 12-20 weeks to therapeutic levels. Dr. Gattoni provides guidance on nutrition strategies that complement peptide therapy, including protein intake targets to preserve lean muscle mass during caloric restriction, hydration protocols, and meal timing considerations. Follow-up appointments occur at regular intervals to assess tolerance, review side effect management strategies, and evaluate progress toward individualized weight loss goals. The practice addresses common patient concerns about medication costs, insurance coverage options, and long-term maintenance strategies, including transition protocols for patients who achieve target weight ranges.

The clinic's location in Denver provides access to Colorado residents throughout the Front Range metropolitan area, with appointment availability structured to accommodate working professionals. Dr. Gattoni's dual focus on weight loss and cosmetic injection services allows patients to address both metabolic health and aesthetic goals within a single practice setting. Her DMSC credential and consistently high patient ratings reflect a commitment to clinical excellence in an evolving field where peptide-based therapies are reshaping obesity treatment paradigms. The practice accepts new patients seeking medically supervised weight loss programs and provides consultation services to determine candidacy for semaglutide or tirzepatide therapy based on BMI criteria, medical history, and treatment objectives.